system deficiencies, pelvic inflammatory disease, 
and toxic shock syndrome; and 
‘‘(B) poses any risks to the health of chil-
dren of women who used such products during 
or before the pregnancies involved, including 
risks relating to fetal and childhood develop-
ment. 
‘‘(2) REQUIREMENT
REGARDING
DATA
FROM 
MANUFACTURERS.—Research under paragraph (1) 
shall include research to confirm the data on tam-
pons and other feminine hygiene products submitted 
to the Commissioner of Food and Drugs by manu-
facturers of such products. 
‘‘(3) DEFINITION.—For purposes of paragraph 
(1), the term ‘feminine hygiene products’ means 
tampons, pads, liners, and similar products used by 
women with respect to menstruation or other gen-
ital-tract secretions. 
‘‘(b) REPORTS.—Reports on the results of research 
under subsection (a) shall be periodically submitted to the 
Congress, the Commissioner of Food and Drugs, the Ad-
ministrator of the Environmental Protection Agency, and 
the Chairman of the Consumer Product Safety Commis-
sion. Such reports shall be made available to the public 
through the data system and clearinghouse program es-
tablished under section 486A, or through other appro-
priate means.’’. 
TITLE 
II—COLLECTION 
AND 
ANALYSIS OF DATA ON TOXIC 
SHOCK SYNDROME 
SEC. 201. FINDINGS. 
The Congress finds as follows: 
(1) Of the cases of toxic shock syndrome in the 
United States, approximately 50 percent are related 
to tampon use and approximately 50 percent occur 
in nonmenstruating women and in men and children. 
(2) The Centers for Disease Control and Pre-
vention (CDC) believes that women are at increased 
risk for developing toxic shock syndrome due to a 
false sense of security that there is no longer any 
risk for developing the disease. 
(3) The CDC has estimated that each year such 
syndrome strikes more than 1,300 individuals. 
Among women in the age group 12 through 44 who 
use tampons or barrier contraceptives, between one 
and two of every 100,000 will develop the syndrome. 
(4) Epidemiological data on cases of toxic shock 
syndrome are not systematically collected in the 
United States, and information on cases seldom
travels beyond the victim’s circle of family and 
friends. 
(5) The CDC and the States should cooperate 
to collect and analyze such data. Increasing the 
amount of information on toxic shock syndrome will 
lead to increased awareness about the disease in the 
medical community, and may also lead to an in-
creased understanding of the causes of the syn-
drome. 
SEC. 202. CENTERS FOR DISEASE CONTROL AND PREVEN-
TION; ESTABLISHMENT OF PROGRAM FOR 
COLLECTION AND ANALYSIS OF DATA ON 
TOXIC SHOCK SYNDROME. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by inserting after sec-
tion 317O the following section: 
‘‘COLLECTION AND ANALYSIS OF DATA ON TOXIC SHOCK 
SYNDROME 
‘‘SEC. 317P. (a) IN GENERAL.—The Secretary, act-
ing through the Director of the Centers for Disease Con-
trol and Prevention, shall carry out a program to collect, 
analyze, and make available data on toxic shock syndrome, 
including data on the causes of such syndrome. 
‘‘(b) NATIONAL INCIDENCE AND PREVALENCE.—In 
carrying out the program under subsection (a), the Sec-
retary shall to the extent practicable determine the na-
tional incidence and prevalence of toxic shock syndrome. 
‘‘(c) COOPERATION WITH STATES.—The Secretary 
may carry out the program under subsection (a) directly 
and through grants to States and local health depart-
ments. 
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated such sums as may be necessary for 
each of the fiscal years 2004 through 2008.’’.
Æ